Lancet to sell African laboratories for $123m
Cerba, a Paris-based medical company, will hold a 51% stake in a joint venture with Lancet
Nairobi — Cerba HealthCare, the French owner of a global network of medical laboratories, is expanding in Africa by buying some of Lancet Laboratories’ operations for as much as 12.5 billion Kenyan shillings ($123m), said a person familiar with the matter. Paris-based Cerba will hold a 51% stake in a joint venture with the SA company that will operate in 11 African countries, said the person who asked not to be identified because the information is not public. Cerba announced on Thursday it started operations in Africa after forming a joint venture known as Cerba Lancet Africa with Lancet, without providing details about the deal. The agreement excludes Lancet’s biggest operations in SA, it said in a statement on its website. Cerba Lancet plans to expand into several other African markets by partnering with local businesses, the company said in an e-mailed response to questions. The growth will be funded jointly by the two companies and bank financing, it said. Lancet did not immedi...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.